Project Grant R03DE034787
Award Date
6/15/25
Completion Date
6/14/27
Dollars Obligated
$323K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Augusta, GA 30912, USA
Similar Awards
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to The Medical University of South Carolina (MUSC) to conduct research on the role of CD38 signaling in aging-associated immune responses induced by oral bacterial pathogens. The goal is to determine if inhibition of CD38 can attenuate inflammatory bone loss and alleviate aging-associated immune responses caused by oral pathogens like...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is focused on developing a novel antibody-based therapy to prevent alveolar bone loss in severe periodontitis. The award, totaling $304,019, will enable the prime awardee, Panorama Research Incorporated, to identify and evaluate a panel of human anti-human OC-STAMP monoclonal antibodies. The goal is to identify a lead antibody...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Augusta University Research Institute, Inc. provides $550,627 in funding over a 5-year period from January 1, 2025 to November 30, 2029. The award will support research investigating the role of oral microbially-induced exosomes in the pathogenesis of Alzheimer's disease and related dementias (ADRD). The key research objectives are to determine how exosomes released during periodontal disease...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $423,500.00 to Nova Southeastern University, Inc. to develop a humanized mouse model of periodontitis. The goal is to investigate the potential pathogenic role of the protein Semaphorin 4D expressed by human osteoclasts in the progression of periodontal disease. This advanced mouse model will allow researchers to...
This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
This $582,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, will support research to investigate the use of epigenetic modulators to reverse the effects of peri-implantitis. The University of Rochester will conduct this 5-year research project, which aims to understand the inflammatory and oxidative stress mechanisms that contribute to peri-implantitis, a common...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $446,875 to support research on the role of a novel G protein-coupled receptor, MRGPRX2, in the development of periodontal disease. The funded research aims to develop two humanized mouse models to study the contribution of MRGPRX2-expressing mast cells to Porphyromonas gingivalis-induced and ligature-induced...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $185,918 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Brigham & Women's Hospital Inc. in Boston, Massachusetts. The grant, effective from February 1, 2025 to January 31, 2027, will evaluate the impact of Medicaid coverage for treatment of periodontal disease on oral health outcomes, emergency department use, healthcare costs, and complications of diabetes among Medicaid...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $432,209 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to the University of California, Los Angeles (UCLA) for a 2-year period starting on August 1, 2023. The funding supports research to investigate the role of the CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus on periodontitis. Specifically, the research aims to further elucidate the role of CXCL10 in the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate the role of T cell immune responses to the oral pathogen Aggregatibacter actinomycetemcomitans (AA) in the development of periodontal disease. The $248,627 award, effective from January 1, 2025 to December 31, 2029, will fund two primary research aims: 1) Assessing systemic T cell responses...